Interestingly, BTNL2 protein expression was significantly increased in LLC tumours after anti-PD-1 mAb treatment (Supplementary Fig. 2d), mirroring the prior report in humans that BTNL2 expression was upregulated following anti-PD-1 treatment48. The gene discussed is PDCD1; the disease is neoplasm.